John Theurer Cancer Center At Hackensack UMC — Hackensack, New Jersey

John Theurer Cancer Center At Hackensack UMC is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

John Theurer Cancer Center At Hackensack UMC has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Multiple Myeloma, Graft-versus-host Disease (GVHD), Essential Thrombocythemia.

Sponsors: GPCR Therapeutics, Inc., Incyte Corporation, PharmaEssentia.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for John Theurer Cancer Center At Hackensack UMC?

John Theurer Cancer Center At Hackensack UMC has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has John Theurer Cancer Center At Hackensack UMC conducted?

John Theurer Cancer Center At Hackensack UMC has 7 clinical trials on record, with 3 currently active. Their work covers Multiple Myeloma, Graft-versus-host Disease (GVHD), Essential Thrombocythemia.

Is John Theurer Cancer Center At Hackensack UMC accredited by Crixeo Health?

Yes — John Theurer Cancer Center At Hackensack UMC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about John Theurer Cancer Center At Hackensack UMC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.